FindTrial
Sign In

The relationship between the expression of ALDHs and the clinicopathological parameters and prognosis of patients with neuroblastoma

The relationship between the expression of ALDHs and the clinicopathological parameters and prognosis of patients with neuroblastoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047751
Enrollment
Unknown
Registered
2021-06-26
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuroblastoma

Interventions

Case series:No

Sponsors

The First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient was diagnosed as neuroblastoma according to the pathological report.

Exclusion criteria

Exclusion criteria: 1. The researchers who are not suitable for clinical trials because of other reasons; 2. Preserving cases with less paraffin tissue.

Design outcomes

Primary

MeasureTime frame
acetaldehyde dehydrogenase;—

Countries

China

Contacts

Public ContactYu Shicang

The First Affiliated Hospital of Army Medical University, PLA

yushicang@163.com+86 13228685391

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026